Search Medical Condition
Please enter condition
Please choose location from dropdown
 

Attention Deficit/Hyperactivity Disorder (ADHD - Pediatric) Clinical Trials

A listing of Attention Deficit/Hyperactivity Disorder (ADHD - Pediatric) medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

RESULTS

Found (36) clinical trials

This study will evaluate the efficacy and safety of high doses of SPN 812 ER in children with ADHD

Phase N/A

This study will evaluate the efficacy and safety of high doses of SPN-812 ER in adolescents (12-17 years old)

Phase N/A

This study is a multicenter, dose-optimized, open-label safety study with KP415 in children with Attention-Deficit/Hyperactivity Disorder (ADHD).

Phase N/A

This study is a multicenter, dose-optimized, open-label safety study with KP415 in children with Attention-Deficit/Hyperactivity Disorder (ADHD).

Phase N/A

The purpose of this study is to demonstrate the efficacy, safety and tolerability of SPN-810 in the treatment of impulsive aggression in subjects with Attention Deficit/Hyperactivity Disorder (ADHD) in conjunction with standard ADHD treatment. Approximately 291 subjects aged 6 to 12 years with ADHD and comorbid impulsive aggression will be ...

Phase N/A

The purpose of this study is to evaluate the effect of 4-week SPN-810 treatment on brain functioning in patients aged 8-12 years with ADHD and associated feature of IA. This will be achieved using functional magnetic resonance imaging (fMRI) in conjunction with the point subtraction aggression paradigm (PSAP) Task, a ...

Phase

Children between the ages of 6-12 years who are diagnosed with impulsive aggression comorbid with ADHD and have participated in the 810P301 or 810P302 study are invited to participate in this study. This is a Phase 3 open label extension (OLE) study with the objective of collecting long-term safety data ...

Phase

This study will evaluate the efficacy and safety of high doses of SPN-812 ER in adolescents (12-17 years old).

Phase

The purpose of this study is to evaluate the effect of SPN-810 for the treatment of impulsive aggression (IA) in adolescents diagnosed with ADHD when taken in conjunction with standard ADHD treatment.  

Phase